Bristol-Myers Squibb Announces Preliminary Court Approval of Derivative Settlement.Detailed Notice to Shareholders Available on Bristol-Myers Squibb Website NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- Bristol-Myers Squibb Company (NYSE NYSE See: New York Stock Exchange :BMY BMY Bristol Myers Squibb ) announced today that the United States District Court United States District Court In the U.S., any of the 94 trial courts of general jurisdiction in the federal judicial system. Each state, as well as the District of Columbia and the Commonwealth of Puerto Rico, has at least one federal district court. for the Southern District of New York has granted preliminary approval of settlement of Sampson v. Robinson, et al., Case No. 1:07-CV-06890 (on appeal: Case No. 08-5475), a shareholder action pursued derivatively on behalf of Bristol-Myers Squibb. The action concerned allegations relating to the efforts to settle the Plavix patent litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. in 2006. The proposed settlement is subject to final Court approval. The Court has set a final approval hearing for December 8, 2009 at 2 p.m. in the courtroom of the Honorable Paul A. Crotty, United States District Judge. As required by the Court's Preliminary Approval Order, Bristol-Myers Squibb is providing shareholders with detailed notice of the terms of the proposed settlement on its website. The notice also contains important information regarding the rights of shareholders with respect to this proposed settlement. We encourage shareholders to read the notice in its entirety. The notice can be found at www.bms.com. About Bristol-Myers Squibb Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to extend and enhance human life. For more information, visit www.bms.com. |
|
|||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion